Medications

Unituxin approved for deadly pediatric cancer

(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.

Mar 11, 2015
popularity 6 comments 0

Most information in drug development is lost

Lots of potentially useful medical information is getting lost. McGill researchers discovered this when they looked into the lack of reporting of information from "stalled drug" trials in cancer, cardiovascular ...

Mar 09, 2015
popularity 8 comments 0